Although antibodies to EPCR-binding CIDRα1.4 domains did not differ overall between all CM cases compared to UM (98), their lower levels in CM children with retinopathy compared to those without suggest a potential role in modulating severity, rather than conferring outright protection from CM. The gene discussed is PROCR; the disease is retinal disorder.